[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"notifications-list":3,"$f3w0yeho4pvwua":5},{"data":4},[],{"data":6,"error":11},{"id":7,"documentId":8,"slug":9,"name":10,"medical_code":11,"short_description":12,"alternate_name":11,"disambiguating_description":11,"citations":13,"drugs":19,"specialties":25,"cover":11},988,"z5wselukrhdwvfxfnjhoxdhw","first-generation-cephalosporins","First-generation cephalosporins",null,"ANTIBACTERIALS FOR SYSTEMIC USE > OTHER BETA-LACTAM ANTIBACTERIALS > First-generation cephalosporins.",[14],{"source":15,"licence":16,"source_url":17,"retrieved_at":18},"UK VMD Summary of Product Characteristics, section 4.1","EMA and VMD register content, Crown\u002FEU public register","https:\u002F\u002Fwww.vmd.defra.gov.uk\u002FProductInformationDatabase\u002Ffiles\u002FSPC_Documents\u002FSPC_3144048.PDF","2026-09-20",[20],{"id":21,"documentId":22,"slug":23,"name":23,"active_ingredient":24,"dosage_form":11,"administration_route":11},1884,"hlm4om58rvm0yingdcppdpcd","cefalexin","Each ml contains:\r Active substance:\r Cefalexin (as cefalexin sodium): 180 mg\r Excipient(s):\r  Qualitative composition of excipients\r  and other constituents\r  Castor oil, hydrogenated\r  Triglycerides, medium-chain\r White to slightly yellow suspension for",[]]